683 Capital Management’s Sanara MedTech SMTI Stock Holding History

683 Capital Management’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,966	Closed	-$226K	–	326
2022 Q4	$226K	Buy	+4,966	New	+$171K	0.02%	145

Other funds holding SMTI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

683 Capital Management's SMTI Position: Q1 2023 in Review

683 Capital Management sold out of Sanara MedTech (SMTI) in Q1 2023, closing a stake of 4,966 shares — an estimated $226K sold.

683 Capital Management first reported a position in SMTI in Q4 2022 and held it in 1 quarter. The position peaked at $226K in Q4 2022. 35 funds tracked by Wall St. Rank hold SMTI as of Q1 2023.

683 Capital Management reported no remaining Sanara MedTech position as of Q1 2023 after selling out during the quarter.
683 Capital Management sold 4,966 Sanara MedTech shares in Q1 2023, an estimated $226K.
683 Capital Management first reported a position in Sanara MedTech in Q4 2022 and held it in 1 quarter.
683 Capital Management's Sanara MedTech position peaked at $226K in Q4 2022.
35 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2023.

Based on 683 Capital Management's 13F filing for Q1 2023, filed 15 May 2023.